RCKT
RCKT
NASDAQ · Biotechnology

Rocket Pharmaceuticals Inc

$3.37
-0.13 (-3.71%)
Analyst Consensus
Buy
20
Analysts
High
Coverage
Buy 11 55%
Hold 7 35%
Sell 2 10%
Price Target
Analyst Price Target +400.6% upside
Low Target $13.87
Average Target $16.87
High Target $23.44
Current Price $3.37
Current
$3.37
Target
$16.87
$13.87 $16.87 avg $23.44
Scenario Analysis
Bear Case
$13.87
311.6%
Low target
Base Case
$16.87
+400.6%
Avg target
Bull Case
$23.44
+595.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$5.45
-38.2% from high
52-Week Low
$2.53
+33.2% from low
Target vs 52W High
$16.87
+209.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.0%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -15.6%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%